Effect of matrix metalloproteinase inhibitors on rat embryo development in vitro

Cells Tissues Organs

Volumn 165, Issue 2, 1999, Pages 67-73

  Del Bigio, Marc R ^a   Seyoum, Girma ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Batimastat; BB 94; Culture, whole embryo; Development; Rat; Tissue inhibitor of metalloproteinase

Indexed keywords

BATIMASTAT; MESSENGER RNA; METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; MATRIX METALLOPROTEINASES; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

ANIMALIA; MAMMALIA;

EID: 0032836629     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016676     Document Type: Article

References (43)

1. Altman, J., S.A. Bayer (1995) Atlas of Prenatal Rat Brain Development. Boca Raton, CRC Press.
2. Apte, S.S., N. Fukai, D.R. Beier, B.R. Olsen (1997) The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J Biol Chem 272: 25511-25517.
3. Beattie, G.J., J.F. Smyth (1998) Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites. Clin Cancer Res 4: 1899-1902.
4. Birkedal-Hansen, H., W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, J.A. Engler (1993) Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4: 197-250.
5. Botos, I., L. Scapozza, D. Zhang, L.A. Liotta, E.F. Meyer (1996) Batimastat, a potent matrix metalloproteinase inhibitor, exhibits an unexpected mode of binding. Proc Natl Acad Sci USA 93: 2749-2754.
6. Brenner, C.A., R.R. Adler, D.A. Rappolee, R.A. Pedersen, Z. Werb (1989) Genes for extracellular matrix-degrading metalloproteinases and their inhibitor, TIMP, are expressed during early mammalian development. Genes Dev 3: 848-859.
7. Brent, R.L., L.B. Fawcett (1998) Nutritional studies of the embryo during early organogenesis with normal embryos and embryos exhibiting yolk sac dysfunction. J Pediatr 132: S6-S16.
8. Brown, N.A., S. Fabro (1981) Quantitation of rat embryonic development in vitro: A morphological scoring system. Teratology 24: 65-78.
9. Canete-Soler, R., Y.H. Gui, K.K. Linask, R.J. Muschel (1995a) Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos. Dev Dynam 204: 30-40.
10. Canete-Soler, R., Y.H. Gui, K.K. Linask, R.J. Muschel (1995b) MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Dev Brain Res 88: 37-52.
11. Chirivi, R.G.S., A. Garafolo, M.J. Crimmin, L.J. Bawden, A. Stoppacciaro, P.D. Brown, R. Giavazzi (1994) Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor. Int J Cancer 58: 460-464.
12. Culling, C.F.A., W.L. Dunn (1974) Handbook of Histopathological and Histochemical Techniques, ed 3. London, Butterworths.
13. Denis, L.J., J. Verweij (1997) Matrix metalloproteinase inhibitors: Present achievements and future prospects. Invest New Drugs 15: 175-185.
14. Fisher, C., S. Gilbertson-Beadling, E.A. Powers, G. Petzold, R. Poorman, M.A. Mitchell (1994) Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162: 499-510.
15. Gack, S., R. Vallon, J. Schmidt, A. Grigoriadis, J. Tuckermann, J. Schenkel, H. Weiher, E.F. Wagner, P. Angel (1995) Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ 6: 759-767.
16. Gomis-Ruth, F.X., K. Maskos, M. Betz, A. Bergner, R. Huber, K. Suzuki, N. Yoshida, H. Nagase, K. Brew, G.P. Bourenkov, H. Bartunik, W. Bode (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77-81.
17. Guest, I., H.S. Buttar, S. Smith, D.R. Varma (1994) Evaluation of the rat embryo culture system as a predictive test for human teratogens. Can J Physiol Pharmacol 72: 57-62.
18. Harvey, M., K. Leco, M. Arcellana-Panlilio, X. Zhang, D. Edwards, G. Schultz (1995) Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Dev Suppl 121: 1005-1014.
19. Huppertz, B., S. Kertschanska, A.Y. Demir, H.G. Frank, P. Kaufmann (1998) Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res 291: 133-148.
20. Itoh, T., T. Ikeda, H. Gomi, S. Nakao, T. Suzuki, S. Itohara (1997) Unaltered secretion of β-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 272: 22389-22392.
21. Johnson, M.D., H.R.C. Kim, L. Chesler, G. Tsao-Wu, N. Bouck, P.J. Polverini (1994) Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194-202.
22. Kinoh, H., H. Sato, Y. Tsunezuka, T. Takino, A. Kawashima, Y. Okada, M. Seiki (1996) MT-MMP, the cell surface activator of proMMP-2 (pro-gelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 109: 953-959.
23. Lefebvre, O., C. Regnier, M.P. Chenard, C. Wendling, P. Chambon, P. Basset, M.C. Rio (1995) Developmental expression of mouse stromelysin-3 mRNA. Development 121: 947-955.
24. Lloyd, J.B., D.A. Beckman, R.L. Brent (1998) Nutritional role of the visceral yolk sac in organogenesis-stage rat embryos. Reprod Toxicol 12: 193-195.
25. Mignatti, P., D.B. Rifkin (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195.
26. Miki, A., E. Fujimoto, T. Ohsaki, H. Mizoguti (1988) Effects of oxygen concentration on embryonic development in rats: A light and electron microscopic study using whole-embryo culture techniques. Anat Embryol 178: 337-343.
27. Milunsky, A., J.S. Morris, H. Jick, K.J. Rothman, M. Ulcickas, S.S. Jick, P. Shoukimas, W. Willett (1992) Maternal zinc and fetal neural tube defects. Teratology 46: 341-348.
28. Morriss-Kay, G., F. Tuckett (1989) Immunohistochemical localisation of chondroitin sulphate proteoglycans and the effects of chondroitinase ABC in 9-to 11-day rat embryos. Development 106: 787-798.
29. Muir, D. (1994) Metalloproteinase-dependent neurite outgrowth within a synthetic extracellular matrix is induced by nerve growth factor. Exp Cell Res 210: 243-252.
30. Nagase, H., A.J. Barrett, J.F. Woessner Jr. (1992) Nomenclature and glossary of the matrix metalloproteinases. Matrix Suppl 1: 421-424.
31. New, D.A., P.T. Coppola, D.L. Cockroft (1976) Improved development of head-fold rat embryos in culture resulting from low oxygen and modifications of the culture serum. J Reprod Fertil 48: 219-222.
32. New, D.A., P.T. Coppola, S. Terry (1973) Culture of explanted rat embryos in rotating tubes. J Reprod Fertil 35: 135-138
33. Nordstrom, L.A., J. Lochner, W. Yeung, G. Ciment (1995) The metalloproteinase stromelysin-1 (transin) mediates PC12 cell growth cone invasiveness through basal laminae. Mol Cell Neurosci 6: 56-68.
34. Rasmussen, U.S., P.P. McCann (1997) Matrix metalloproteinase inhibition as a novel anticancer strategy: A review with special focus on batimastat and marimastat. Pharmacol Ther 75: 69-75.
35. Sanders, E.J., M.A. Wride (1997) Roles for growth and differentiation factors in avian embryonic development. Poult Sci 76: 111-117.
36. Solorzano, C.C., R. Ksontini, J.H. Pruitt, T. Auffenberg, C. Tannahill, R.E. Galardy, G.P. Schultz, S.L. MacKay, E.M. Copeland 3rd, L.L. Moldawer (1997) A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. Shock 7: 427-431.
37. Sympson, C.J., R.S. Talhouk, C.M. Alexander, J.R. Chin, S.M. Cliff, M.J. Bissel, Z. Werb (1994) Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125: 681-693.
38. Taraboletti, G., A. Garofalo, D. Belotti, T. Drudis, P. Borsotti, E. Scanziani, P.D. Brown, R. Giavazzi (1995) Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases. J Natl Cancer Inst 87: 293-298.
39. Wilson, C.L., K.J. Heppner, P.A. Labosky, B.L.M. Hogan, L.M. Matrisian (1997) Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Nat Acad Sci USA 94: 1402-1407.
40. Witty, J.P., J.H. Wright, L.M. Matrisian (1995) Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 6: 1287-1303.
41. Wojtowicz-Praga, S.M., R.B. Dickson, M.J. Hawkins (1997) Matrix metalloproteinase inhibitors. Invest New Drugs 15: 61-75.
42. Wride, M.A., E.J. Sanders (1995) Potential roles for tumour necrosis factor alpha during embryonic development. Anat Embryol 191: 1-10.
43. Yoshida, Y., M. Yamada, K. Wakabayashi, K. Oyanagi, F. Ikuta (1988) Early development of cerebral blood vessels: On the relationship between cerebral histogenesis and internal vascularization (in Japanese). No To Shinkei 40: 657-664.